Genomics and transcriptomics are essential for understanding what could happen in biology. Proteins reveal what is happening — the mechanisms driving disease, treatment response, toxicity, and patient heterogeneity. For drug development teams, that missing protein layer can determine whether biomarkers translate from discovery into the clinic. Discover how Nomic's scalable, quantitative proteomics platform transforms this missing layer into the discovery engine that drives confident decisions from hit to clinic.